Current Gene Therapy
Volume 22, 5 Issues, 2022
ISSN: 1566-5232 (Print)
ISSN: 1875-5631 (Online)
This journal supports open access
ISSN: 1566-5232 (Print)
ISSN: 1875-5631 (Online)
This journal supports open access
Call for Editors
Current Gene Therapy is recruiting Editors in the following Hot Areas of the Journal. If you are interested to join, then please submit your details for the Editor in Chief’s consideration below.
- Cancer Gene Therapy
- Carcinogenesis
- Epigenetics
- Gene Editing
- Gene Expression Analysis
- Gene Mutation
- Gene Replacement Therapy
- Gene Therapy Vectors
- Genetic Disorders
- Genetic Engineering
- Hemophilia
- Human Gene Therapy
- Lentiviral Gene Therapy
- Plasmid DNA
- RNA-Based Therapeutics
- RNAi-Based Gene Therapy
- Stem Cell Gene Therapy
- Systemic Gene Delivery
- Transcription Factors
- Viral Vectors for Gene Therapy
* If you are willing to become an Editor, in any other section (not listed above), which you feel is relevant to Journals' scope, then please inform us by choosing the “Others” option from the drop down list when you are filling the form below.
Responsibilities:
- Editors are responsible to contribute 1 thematic issue each year in a their area of interest. We expect to receive thematic issue proposals from section editors within 4 months of their appointment, a list of potential authors (with a respectable h-index) within 6 months and the complete thematic issue within 9 months.
- Editors are also expected to occasionally solicit/contribute review articles.
- Promote the thematic issue amongst the research community to increase its visibility
Selection Criteria:
Selection by the Editor-in-Chief will be based on, but not limited to, the following factors:
- Interested candidates must at least hold a Doctorate degree
- A broad and extensive knowledge of the field
- Previous editorial experience would be desirable
Editor Details
* These fields are mandatory.
Editor-in-Chief
Liang Cheng
College of Bioinformatics, Science and Technology
Harbin Medical University
Harbin, Heilongjiang
(China)
Biography
College of Bioinformatics, Science and Technology
Harbin Medical University
Harbin, Heilongjiang
Biography
Biography of Liang Cheng
Dr. Cheng obtained a doctorate (Ph.D.) in Bioinformatics from Harbin Institute of Technology, Harbin, Heilongjiang, China. Currently Dr. Cheng is a Professor and PI of Biological Software Engineering in Harbin Medical University. He has published more than 70 scientific publications since 2013. Dr. Cheng develops novel algorithms and tools for gene therapy of Type 2 Diabetes Mellitus and complex diseases.
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Board Recruitment Workflow⇨ Short Guide⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments⇨ Special Offers
For Authors
For Librarians & Readers
Quick Links
Webmaster Contact: info@benthamscience.net